EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acceptability, Feasibility, Drug Safety, and Effectiveness of a Pilot Mass Drug Administration with a Single Round of Sulfadoxine–Pyrimethamine Plus Primaquine and Indoor Residual Spraying in Communities with Malaria Transmission in Haiti, 2018

Michelle A Chang, Daniel Impoinvil, Karen E S Hamre, Paul-Emile Dalexis, Jean-Baptiste Mérilien, Amber M Dismer, Bernadette Fouché, Luccene Desir, Kathleen Holmes, Willy Lafortune, Camelia Herman, Eric Rogier und 15 weitere

The American Journal of Tropical Medicine and Hygiene · 2023

DOI: 10.4269/ajtmh.22-0623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2023. Verfasst von Michelle A Chang und 26 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Branch, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia. Hauptthemen laut MEDLINE: Malaria, Insecticides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For a malaria elimination strategy, Haiti’s National Malaria Control Program piloted a mass drug administration (MDA) with indoor residual spraying (IRS) in 12 high-transmission areas across five communes after implementing community case management and strengthened surveillance. The MDA distributed sulfadoxine–pyrimethamine and single low-dose primaquine to eligible residents during house visits. The IRS campaign applied pirimiphos–methyl insecticide on walls of eligible houses. Pre- and post-campaign cross-sectional surveys were conducted to assess acceptability, feasibility, drug safety, and effectiveness of the combined interventions. Stated acceptability for MDA before the campaign was 99.2%; MDA coverage estimated at 10 weeks post-campaign was 89.6%. Similarly, stated acceptability of IRS at baseline was 99.9%; however, household IRS coverage was 48.9% because of the high number of ineligible houses. Effectiveness measured by Plasmodium falciparum prevalence at baseline and 10 weeks post-campaign were similar: 1.31% versus 1.43%, respectively. Prevalence of serological markers were similar at 10 weeks post-campaign compared with baseline, and increased at 6 months. No severe adverse events associated with the MDA were identified in the pilot; there were severe adverse events in a separate, subsequent campaign. Both MDA and IRS are acceptable and feasible interventions in Haiti. Although a significant impact of a single round of MDA/IRS on malaria transmission was not found using a standard pre- and post-intervention comparison, it is possible there was blunting of the peak transmission. Seasonal malaria transmission patterns, suboptimal IRS coverage, and low baseline parasitemia may have limited the effectiveness or the ability to measure effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MalariaInsecticidesHumansPrimaquineMass Drug AdministrationCross-Sectional StudiesHaitiFeasibility StudiesMosquito ControlDrug CombinationsPyrimethamineSulfadoxine

Substanzen

PrimaquineInsecticidesfanasil, pyrimethamine drug combinationDrug CombinationsPyrimethamineSulfadoxine

Autor:innen und Institutionen

  • Malaria Branch, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Entomology Branch, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
  • CDC Foundation, Atlanta, Georgia.
  • IMA World Health, Port-au-Prince, Haiti.
  • Programme National de Contrôle de la Malaria, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti.
  • Emergency Response and Recovery Branch, Center for Global Health, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia.

Zitieren

APA

Chang, M. A., Impoinvil, D., Hamre, K. E. S., Dalexis, P. E., Mérilien, J. B., Dismer, A. M., Fouché, B., Desir, L., Holmes, K., Lafortune, W., Herman, C., Rogier, E., Noland, G. S., Young, A. J., Druetz, T., Ashton, R., Eisele, T. P., Cohen, J., van den Hoogen, L., …, & Lemoine, J. F. (2023). Acceptability, Feasibility, Drug Safety, and Effectiveness of a Pilot Mass Drug Administration with a Single Round of Sulfadoxine–Pyrimethamine Plus Primaquine and Indoor Residual Spraying in Communities with Malaria Transmission in Haiti, 2018. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.22-0623

Vancouver

Chang MA, Impoinvil D, Hamre KES, Dalexis PE, Mérilien JB, Dismer AM, et al. Acceptability, Feasibility, Drug Safety, and Effectiveness of a Pilot Mass Drug Administration with a Single Round of Sulfadoxine–Pyrimethamine Plus Primaquine and Indoor Residual Spraying in Communities with Malaria Transmission in Haiti, 2018. The American Journal of Tropical Medicine and Hygiene. 2023. doi:10.4269/ajtmh.22-0623

BibTeX
@article{Chang2023,
  author = {Chang, Michelle A and Impoinvil, Daniel and Hamre, Karen E S and Dalexis, Paul-Emile and Mérilien, Jean-Baptiste and Dismer, Amber M and Fouché, Bernadette and Desir, Luccene and Holmes, Kathleen and Lafortune, Willy and Herman, Camelia and Rogier, Eric and Noland, Gregory S and Young, Alyssa J and Druetz, Thomas and Ashton, Ruth and Eisele, Thomas P and Cohen, Justin and van den Hoogen, Lotus and Stresman, Gillian and Drakeley, Chris and Pothin, Emilie and Cameron, Ewan and Battle, Katherine E and Williamson, John and Telfort, Marc-Aurèle and Lemoine, Jean Frantz},
  title = {Acceptability, Feasibility, Drug Safety, and Effectiveness of a Pilot Mass Drug Administration with a Single Round of Sulfadoxine–Pyrimethamine Plus Primaquine and Indoor Residual Spraying in Communities with Malaria Transmission in Haiti, 2018},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2023},
  doi = {10.4269/ajtmh.22-0623}
}
Kostenlos starten →